New 'Superaspirin' Helps Prevent Colon Cancer in Mice
Posted on: Monday, 29 November 2004, 09:00 CST
A recent study indicates a powerful form of aspirin appears to help prevent colon cancer in mice without raising the incidence of gatrointestinal bleeding.
The drug is called nitric oxide-donating aspirin, or nitroaspirin. Researcher Dr. Basil Rigas, chief of the Division of Cancer Prevention at SUNY Stony Brook, N.Y., says that while the studies are preliminary, nitroaspirin also may have a positive effect against cardiovascular disease and help ease the pain of arthritis. The compound, he said, is much more powerful than regular aspirin, and much safer.
Rigas said the difference between common aspirin and nitroaspirin is that the molecule of aspirin has been modified to release nitric oxide. That, in turn, has multiple effects on the cardiovascular and respiratory systems, as well as cancer.
The full text of a HealthDay news service story on Rigas' study, as well as more information on "superaspirin," can be found at www.healthday.com. Search Archive using the keyword "aspirin."
Source: Intelligencer Journal
Related Articles
- Aspirin May Protect Men, but Not Women Cancer Researchers Release Separate Studies
- Studies Don't Settle Debate on Cancer Risk, Aspirin
- 2 Large Studies Differ on Value of Aspirin As Cancer Fighter
- Studies: Aspirin Cuts Cancer in Men, Not Women
- Studies Show Contrast on Aspirin, Cancer
- Study Finds Aspirin, Vitamin E Don't Prevent Cancer
- Nitroaspirin Seen to Ward Off Colon Cancer
- New 'Superaspirin' Prevents Colon Cancer in Mice
- Aspirin to Be Tested in Cancer Fight
 |
 |
User Comments (0)
RSS Feeds